KARLIN DANIEL (Chief Medical Officer) sold 1.4% of their position (10.85K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $396.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/30/2026ACC: 0001104659-26-112065
Officer· Chief Medical Officer
Since Jan 2022
-10.85K
Net shares
Net seller
$396.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.85K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−10.85K
Price / share
$36.57
Trade value
$396.89K
% of position
1.4%
9/25/2026
803.70K→792.85K
Total
Net shares
−10.85K
Net value
-$396.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/25/2026 | S · Sale | −10.85K | $36.57 | $396.89K | 1.4% | 803.70K | 792.85K |
| Total | −10.85K | -$396.89K | ||||||
Derivative Transactions0
No derivative transactions reported